IRB Membership

I am proud to announce that I will become a member of the NCI’s Central IRB for early phase development starting in January 2020. I am looking forward to this exciting opportunity and experience.

The NCI Central IRB is the responsible IRB for all NCI funded studies.  Under current NIH policy, all NCI funded studies must be reviewed and managed by a single IRB, even for multi-center trials.  This committee primarily deals with early phase (Phase 1 and 2) clinical trials for potential new cancer treatments